Avilar Therapeutics Inc

Avilar Therapeutics, Inc. discovers and develops biopharmaceutical therapies targeting disease-causing extracellular proteins. The Company builds a proprietary drug discovery platform and develops extracellular protein degraders as therapeutics. Avilar Therapeutics Inc serves pharmaceutical and biotechnology companies, healthcare providers, and patients in the United States.